Drug and Therapeutics Bulletin 1995;33:28-29; doi:10.1136/dtb.1995.33428
Copyright © 1995 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Drug-resistant tuberculosis

Relevant BNF section: 5.1

Notifications of tuberculosis in England and Wales declined steadily until 1987, when about 5100 cases were reported.1 Since then numbers have begun to rise, reaching a provisional figure of about 5700 in 1994.2 The proportion of isolates of Mycobacterium tuberculosis resistant to one or more conventional first-line antituberculosis drugs has remained steady at about 10%.3 The incidence of tuberculosis is also rising in other countries, but the speed of increase and the proportion of infections that are drug resistant vary. In this article we discuss drug-resistant tuberculosis in the UK and consider its prevention, treatment and control.




This article has been cited by other articles:


Home page
 BMJHome page
D. Raistrick, A. Hay, and K. Wolff
Lesson of the Week: Methadone maintenance and tuberculosis treatment
BMJ, October 12, 1996; 313(7062): 925 - 926.
[Full Text]


About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1995 BMJ Publishing Group Ltd.